(Q40506875)

21 September 2017

0 references

Bacterial infections in low-risk, febrile neutropenic patients (English)

1 reference

21 September 2017

Mallika Kamana

1

1 reference

21 September 2017

Carmelita Escalante

2

1 reference

21 September 2017

Craig A Mullen

3

1 reference

21 September 2017

Susan Frisbee-Hume

4

1 reference

21 September 2017

Kenneth V I Rolston

5

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

21 September 2017

1 reference

21 September 2017

volume

104

1 reference

21 September 2017

issue

2

1 reference

21 September 2017

page(s)

422-426

1 reference

The changing epidemiology of infections at cancer hospitals

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21144

From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21144

Evaluation of new anti-infective drugs for the treatment of febrile episodes in neutropenic patients. Infectious Diseases Society of America and the Food and Drug Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21144

Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21144

Septicemia and Shock Syndrome Due to Viridans Streptococci: A Case-Control Study of Predisposing Factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21144

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21144

7 January 2021

Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21144

7 January 2021

Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21144

7 January 2021

Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21144

7 January 2021

Management of fever in patients with cancer and treatment-induced neutropenia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21144

7 January 2021

Polymicrobial septicemia in the cancer patient

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21144

7 January 2021

Current Spectrum of Bacterial Infections in Patients with Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21144

7 January 2021

Neutropenic enterocolitis: spectrum of the disease and comparison of definite and possible cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21144

7 January 2021

Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21144

7 January 2021

The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21144

7 January 2021

New trends in patient management: risk-based therapy for febrile patients with neutropenia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21144

7 January 2021

Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21144

7 January 2021

From the Immunocompromised Host Society. The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. Report of a consensus panel

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21144

7 January 2021

Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21144

7 January 2021

Nosocomial bloodstream infections in United States hospitals: a three-year analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21144

7 January 2021

Methodology for clinical trials involving patients with cancer who have febrile neutropenia: updated guidelines of the Immunocompromised Host Society/Multinational Association for Supportive Care in Cancer, with emphasis on outpatient studies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21144

7 January 2021

Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: results of a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21144

7 January 2021

Oral antibiotics with early hospital discharge compared with in-patient intravenous antibiotics for low-risk febrile neutropenia in patients with cancer: a prospective randomised controlled single centre study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21144

7 January 2021

Contemporary antimicrobial susceptibility patterns of bacterial pathogens commonly associated with febrile patients with neutropenia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21144

7 January 2021

Bacteremia due to viridans streptococci in neutropenic patients: a review

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21144

7 January 2021

Streptococcal bacteremia in adult patients with leukemia undergoing aggressive chemotherapy. A review of 55 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21144

7 January 2021

Streptococcus mitis sepsis in bone marrow transplant patients receiving oral antimicrobial prophylaxis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21144

7 January 2021

Serious complications of bacteremia caused by Viridans streptococci in neutropenic patients with cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21144

7 January 2021

Oral antibiotic administration and early hospital discharge is a safe and effective alternative for treatment of low-risk neutropenic fever

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21144

7 January 2021

Identifiers

DOI

10.1002/CNCR.21144

1 reference

21 September 2017

1 reference